Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001640334-25-000913
Filing Date
2025-05-20
Accepted
2025-05-20 09:48:52
Documents
79
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q gevi_10q.htm   iXBRL 10-Q 1077170
2 CERTIFICATION gevi_ex311.htm EX-31.1 13209
3 CERTIFICATION gevi_ex312.htm EX-31.2 11219
4 CERTIFICATION gevi_ex321.htm EX-32.1 6044
  Complete submission text file 0001640334-25-000913.txt   5686117

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA gevi-20250331.xsd EX-101.SCH 71199
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE gevi-20250331_lab.xml EX-101.LAB 341653
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gevi-20250331_cal.xml EX-101.CAL 54112
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gevi-20250331_pre.xml EX-101.PRE 293951
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gevi-20250331_def.xml EX-101.DEF 175672
82 EXTRACTED XBRL INSTANCE DOCUMENT gevi_10q_htm.xml XML 1024263
Mailing Address 1740H DEL RANGE BLVD SUITE 166 CHEYENNE WY 82009
Business Address 1740H DEL RANGE BLVD SUITE 166 CHEYENNE WY 82009 800-401-4535
General Enterprise Ventures, Inc. (Filer) CIK: 0000894556 (see all company filings)

EIN.: 872765150 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-56567 | Film No.: 25966657
SIC: 2800 Chemicals & Allied Products
(CF Office: 08 Industrial Applications and Services)